ESMO
October 23, 2023
European Society for Medical Oncology (ESMO) Congress 2023, October 20-24, 2023
Year
2023
Target
RVU120 (CDK8/CDK19)
Assets in this page
Download assets
- pdf file
Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor, in patients with relapsed/refractory metastatic or advanced solid tumors
Download